Key facts
- This page summarizes Sam Ropp's Form 4 filing for Singular Genomics Systems, Inc..
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 19 Mar 2024, 17:49.
Sam Ropp - 15 Mar 2024 Form 4 Insider Report for Singular Genomics Systems, Inc.
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- N/A
- Reported as of
- 15 Mar 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 19 Mar 2024, 17:49:00 UTC
- Prior SEC filing
- 13 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Dalen Meeter, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Sam Ropp filed Form 4 for Singular Genomics Systems, Inc. on 19 Mar 2024.
Change
- Previous filing in this sequence was filed on 13 Feb 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OMIC
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +4,187
- Change %
- +33%
- Price
- Shares after
- 16,750
- Date
- 15 Mar 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OMIC
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -4,187
- Change %
- -7.7%
- Price
- Shares after
- 50,250
- Date
- 15 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,187
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Sam Ropp is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
Footnote F2
Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
Footnote F3
The RSUs vest in 16 equal quarterly installments measured from March 15, 2023.